Smartphones for Opiate Addiction Recovery

Eligibility Criteria

• * Meet DSM-5 criteria for opioid-use disorder (heroin and/or prescription opioids);
• * Have entered, or expressed a clear intention to enter, an OUD treatment program that prescribes either methadone or buprenorphine
• * Any gender;
• * 18 years of age and older;
• * Have used opioids other than as specifically prescribed within thirty days prior to consent;
• * In good-enough general health;
• * Capacity to provide written informed consent as assessed by our Subject Comprehension Assessment Tool(subjects lacking the ability to consent will not be enrolled) ;
• * Able to speak English sufficiently to understand the study procedures and provide written informed consent to participate in the study.
• * Licensed MD employed by the respective site, or at a clinical partner of the respective site, where they will act as participants and be part of the treatment team
• * Currently practicing in the treatment of OUD with either Buprenorphine or Methadone;
• * Able to speak, read, and write English fluently and to provide informed consent in English
• * Licensed MSW, NP, or MD; who are not part of any treatment team within the study and may be employees of their respective sites or other treatment facilities.
• * Currently practicing in the treatment of OUD with either Buprenorphine or Methadone;
• * Able to speak, read, and write English fluently and to provide informed consent in English
• * Serious medical, psychiatric or non-opioid substance use disorder that, in the opinion of a study physician, would make study participation hazardous to the participant or compromise study findings or would prevent the participant from completing the study. Examples include: (a) Disabling or terminal medical illness (e.g., uncompensated heart failure, cirrhosis or end-stage liver disease) as assessed by medical history, review of systems, physical exam and/or laboratory assessments;
• * Severe, untreated or inadequately treated mental disorder (e.g., active psychosis, uncontrolled manic-depressive illness) as assessed by history and/or clinical interview;
• * Current severe alcohol, benzodiazepine, or other depressant or sedative hypnotic use likely to require a complicated medical detoxification (routine alcohol and sedative detoxifications may be included);
• * Suicidal or homicidal ideation that requires immediate attention;
• * Presence of pain of sufficient severity as to require ongoing pain management with opioids;
• * Pending legal action or other reasons that might prevent an individual from completing the study.
• * Pregnancy as assessed by urine pregnancy testing
• * Breastfeeding of infants, as assessed by self-report.
• * Prisoners, as defined by OHRP, are excluded from participation in the study.
• * Individuals receiving residential court-ordered substance abuse treatment.
• * none
• * none